Senator Ron Wyden Calls Ka-Year Price of New Alzheimer's Drug 'Unconscionable'

Senator Ron Wyden Calls $56Ka-Year Price of New Alzheimer's Drug 'Unconscionable'

by

Sen. Chairman Ron Wyden (D-OR) questions Internal Revenue Service (IRS) Commissioner Charles Rettig during a Senate Finance Committee …

Full story here.

Originally published 2021-06-10 12:52:30 — www.newsweek.com

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *

Close Search Window
Designed by Dannci